HEADER HORMONE/GROWTH FACTOR RECEPTOR 24-SEP-03 1R1K TITLE CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAINS OF THE HETERODIMER TITLE 2 ECR/USP BOUND TO PONASTERONE A COMPND MOL_ID: 1; COMPND 2 MOLECULE: ECDYSONE RECEPTOR; COMPND 3 CHAIN: D; COMPND 4 FRAGMENT: HORMONE BINDING DOMAIN; COMPND 5 SYNONYM: ECDYSTEROID RECEPTOR, 20-HYDROXY-ECDYSONE RECEPTOR, 20E COMPND 6 RECEPTOR, HVECR; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ULTRASPIRACLE PROTEIN; COMPND 10 CHAIN: A; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HELIOTHIS VIRESCENS; SOURCE 3 ORGANISM_COMMON: TOBACCO BUDWORM; SOURCE 4 ORGANISM_TAXID: 7102; SOURCE 5 GENE: ECR OR NR1H1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET32B; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HELIOTHIS VIRESCENS; SOURCE 13 ORGANISM_COMMON: TOBACCO BUDWORM; SOURCE 14 ORGANISM_TAXID: 7102; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 18 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 19 EXPRESSION_SYSTEM_PLASMID: PACYC11B KEYWDS NUCLEAR RECEPTOR, TRANSCRIPTION REGULATION, HETERODIMER, ALPHA- KEYWDS 2 HELICAL SANDWICH, STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL KEYWDS 3 GENOMICS, HORMONE-GROWTH FACTOR RECEPTOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR I.M.L.BILLAS,T.IWEMA,J.-M.GARNIER,A.MITSCHLER,N.ROCHEL,D.MORAS, AUTHOR 2 STRUCTURAL PROTEOMICS IN EUROPE (SPINE) REVDAT 3 23-AUG-23 1R1K 1 REMARK HETSYN REVDAT 2 24-FEB-09 1R1K 1 VERSN REVDAT 1 18-NOV-03 1R1K 0 JRNL AUTH I.M.L.BILLAS,T.IWEMA,J.M.GARNIER,A.MITSCHLER,N.ROCHEL, JRNL AUTH 2 D.MORAS JRNL TITL STRUCTURAL ADAPTABILITY IN THE LIGAND-BINDING POCKET OF THE JRNL TITL 2 ECDYSONE HORMONE RECEPTOR. JRNL REF NATURE V. 426 91 2003 JRNL REFN ISSN 0028-0836 JRNL PMID 14595375 JRNL DOI 10.1038/NATURE02112 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 13637 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.243 REMARK 3 FREE R VALUE : 0.304 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1388 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3797 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 8 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1R1K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 25-SEP-03. REMARK 100 THE DEPOSITION ID IS D_1000020325. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-SEP-02 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM30A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9798 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13703 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05200 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.38000 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: VITAMIN D RECEPTOR, PDB ENTRY 1DB1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, AMMONIUM SULFATE, PH 5.6, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 100.89867 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 201.79733 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 201.79733 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 100.89867 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12050 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -50.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 605.39200 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY D 267 REMARK 465 SER D 268 REMARK 465 HIS D 269 REMARK 465 MET D 270 REMARK 465 ALA D 271 REMARK 465 SER D 272 REMARK 465 MET D 273 REMARK 465 THR D 274 REMARK 465 GLY D 275 REMARK 465 GLY D 276 REMARK 465 GLN D 277 REMARK 465 GLN D 278 REMARK 465 MET D 279 REMARK 465 GLY D 280 REMARK 465 ARG D 281 REMARK 465 ASP D 282 REMARK 465 PRO D 283 REMARK 465 LEU D 284 REMARK 465 LYS D 285 REMARK 465 ASN D 286 REMARK 465 GLN D 324 REMARK 465 SER D 325 REMARK 465 ASP D 326 REMARK 465 GLU D 327 REMARK 465 ASP D 328 REMARK 465 ASP D 329 REMARK 465 GLU D 330 REMARK 465 ASP D 530 REMARK 465 VAL D 531 REMARK 465 ALA D 532 REMARK 465 MET A 204 REMARK 465 GLU A 305 REMARK 465 ARG A 306 REMARK 465 ASP A 307 REMARK 465 GLY A 308 REMARK 465 VAL A 309 REMARK 465 ASP A 310 REMARK 465 GLY A 311 REMARK 465 THR A 312 REMARK 465 GLY A 313 REMARK 465 ASN A 314 REMARK 465 ASN A 456 REMARK 465 HIS A 457 REMARK 465 ALA A 458 REMARK 465 PRO A 459 REMARK 465 PRO A 460 REMARK 465 ILE A 461 REMARK 465 ASP A 462 REMARK 465 THR A 463 REMARK 465 ASN A 464 REMARK 465 MET A 465 REMARK 465 MET A 466 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN D 321 CG CD OE1 NE2 REMARK 470 THR D 322 CB OG1 CG2 REMARK 470 TRP D 323 CB CG CD1 CD2 NE1 CE2 CE3 REMARK 470 TRP D 323 CZ2 CZ3 CH2 REMARK 470 ARG D 337 CG CD NE CZ NH1 NH2 REMARK 470 LYS D 517 CG CD CE NZ REMARK 470 VAL D 528 CG1 CG2 REMARK 470 GLU A 304 CG CD OE1 OE2 REMARK 470 ARG A 315 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O SER D 478 N SER D 480 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 SD MET A 329 SD MET A 329 4557 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 268 C - N - CA ANGL. DEV. = 9.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO D 289 -136.29 -94.34 REMARK 500 THR D 291 -167.82 -62.13 REMARK 500 SER D 312 152.91 -41.96 REMARK 500 THR D 322 123.69 152.11 REMARK 500 ARG D 409 -80.42 -62.26 REMARK 500 LYS D 410 -53.64 -25.21 REMARK 500 ALA D 414 -19.04 -49.84 REMARK 500 MET D 431 74.55 55.63 REMARK 500 HIS D 436 -72.92 -46.47 REMARK 500 GLN D 454 54.31 -109.03 REMARK 500 ALA D 479 57.05 -54.64 REMARK 500 VAL D 485 -37.60 -35.40 REMARK 500 SER D 510 9.70 -59.99 REMARK 500 ASN D 515 77.64 46.06 REMARK 500 LYS D 517 103.91 -50.16 REMARK 500 PRO D 519 132.40 -33.30 REMARK 500 ASP A 222 77.68 -107.96 REMARK 500 PRO A 223 62.96 -59.30 REMARK 500 ASN A 237 41.92 -109.08 REMARK 500 PRO A 239 153.38 -42.26 REMARK 500 PRO A 268 99.24 -38.62 REMARK 500 HIS A 269 -24.59 93.87 REMARK 500 LEU A 273 158.21 -45.86 REMARK 500 GLU A 300 -72.27 -55.17 REMARK 500 PHE A 301 9.07 -54.09 REMARK 500 THR A 316 -43.41 -152.81 REMARK 500 SER A 350 -65.63 -94.28 REMARK 500 LEU A 352 -68.10 -105.71 REMARK 500 ARG A 407 32.34 -159.53 REMARK 500 SER A 408 -12.87 -43.68 REMARK 500 HIS A 439 21.65 49.69 REMARK 500 ALA A 442 45.44 -84.55 REMARK 500 ASP A 443 -79.80 -19.47 REMARK 500 ARG A 451 -75.08 -51.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P1A D 3000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EPH A 4000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1R20 RELATED DB: PDB REMARK 900 RELATED ID: IGBMC-0090-000 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 NO SUITABLE SEQUENCE DATABASE REFERENCE WAS REMARK 999 AVAILABLE FOR CHAINS A OR D, AT THE TIME OF REMARK 999 PROCESSING THIS FILE DBREF 1R1K D 284 532 UNP O18473 ECR_HELVI 305 550 DBREF 1R1K A 205 466 UNP Q7SIF6 Q7SIF6_HELVI 3 264 SEQRES 1 D 266 GLY SER HIS MET ALA SER MET THR GLY GLY GLN GLN MET SEQRES 2 D 266 GLY ARG ASP PRO LEU LYS ASN VAL PRO PRO LEU THR ALA SEQRES 3 D 266 ASN GLN LYS SER LEU ILE ALA ARG LEU VAL TRP TYR GLN SEQRES 4 D 266 GLU GLY TYR GLU GLN PRO SER GLU GLU ASP LEU LYS ARG SEQRES 5 D 266 VAL THR GLN THR TRP GLN SER ASP GLU ASP ASP GLU ASP SEQRES 6 D 266 SER ASP MET PRO PHE ARG GLN ILE THR GLU MET THR ILE SEQRES 7 D 266 LEU THR VAL GLN LEU ILE VAL GLU PHE ALA LYS GLY LEU SEQRES 8 D 266 PRO GLY PHE ALA LYS ILE SER GLN SER ASP GLN ILE THR SEQRES 9 D 266 LEU LEU LYS ALA CYS SER SER GLU VAL MET MET LEU ARG SEQRES 10 D 266 VAL ALA ARG ARG TYR ASP ALA ALA THR ASP SER VAL LEU SEQRES 11 D 266 PHE ALA ASN ASN GLN ALA TYR THR ARG ASP ASN TYR ARG SEQRES 12 D 266 LYS ALA GLY MET ALA TYR VAL ILE GLU ASP LEU LEU HIS SEQRES 13 D 266 PHE CYS ARG CYS MET TYR SER MET MET MET ASP ASN VAL SEQRES 14 D 266 HIS TYR ALA LEU LEU THR ALA ILE VAL ILE PHE SER ASP SEQRES 15 D 266 ARG PRO GLY LEU GLU GLN PRO LEU LEU VAL GLU GLU ILE SEQRES 16 D 266 GLN ARG TYR TYR LEU ASN THR LEU ARG VAL TYR ILE LEU SEQRES 17 D 266 ASN GLN ASN SER ALA SER PRO ARG CYS ALA VAL ILE PHE SEQRES 18 D 266 GLY LYS ILE LEU GLY ILE LEU THR GLU ILE ARG THR LEU SEQRES 19 D 266 GLY MET GLN ASN SER ASN MET CYS ILE SER LEU LYS LEU SEQRES 20 D 266 LYS ASN ARG LYS LEU PRO PRO PHE LEU GLU GLU ILE TRP SEQRES 21 D 266 ASP VAL ALA ASP VAL ALA SEQRES 1 A 263 MET VAL GLN GLU LEU SER ILE GLU ARG LEU LEU GLU MET SEQRES 2 A 263 GLU SER LEU VAL ALA ASP PRO SER GLU GLU PHE GLN PHE SEQRES 3 A 263 LEU ARG VAL GLY PRO ASP SER ASN VAL PRO PRO LYS PHE SEQRES 4 A 263 ARG ALA PRO VAL SER SER LEU CYS GLN ILE GLY ASN LYS SEQRES 5 A 263 GLN ILE ALA ALA LEU VAL VAL TRP ALA ARG ASP ILE PRO SEQRES 6 A 263 HIS PHE SER GLN LEU GLU MET GLU ASP GLN ILE LEU LEU SEQRES 7 A 263 ILE LYS GLY SER TRP ASN GLU LEU LEU LEU PHE ALA ILE SEQRES 8 A 263 ALA TRP ARG SER MET GLU PHE LEU THR GLU GLU ARG ASP SEQRES 9 A 263 GLY VAL ASP GLY THR GLY ASN ARG THR THR SER PRO PRO SEQRES 10 A 263 GLN LEU MET CYS LEU MET PRO GLY MET THR LEU HIS ARG SEQRES 11 A 263 ASN SER ALA LEU GLN ALA GLY VAL GLY GLN ILE PHE ASP SEQRES 12 A 263 ARG VAL LEU SER GLU LEU SER LEU LYS MET ARG THR LEU SEQRES 13 A 263 ARG VAL ASP GLN ALA GLU TYR VAL ALA LEU LYS ALA ILE SEQRES 14 A 263 ILE LEU LEU ASN PRO ASP VAL LYS GLY LEU LYS ASN ARG SEQRES 15 A 263 GLN GLU VAL GLU VAL LEU ARG GLU LYS MET PHE LEU CYS SEQRES 16 A 263 LEU ASP GLU TYR CYS ARG ARG SER ARG SER SER GLU GLU SEQRES 17 A 263 GLY ARG PHE ALA ALA LEU LEU LEU ARG LEU PRO ALA LEU SEQRES 18 A 263 ARG SER ILE SER LEU LYS SER PHE GLU HIS LEU PHE PHE SEQRES 19 A 263 PHE HIS LEU VAL ALA ASP THR SER ILE ALA GLY TYR ILE SEQRES 20 A 263 ARG ASP ALA LEU ARG ASN HIS ALA PRO PRO ILE ASP THR SEQRES 21 A 263 ASN MET MET HET P1A D3000 33 HET EPH A4000 49 HETNAM P1A 2,3,14,20,22-PENTAHYDROXYCHOLEST-7-EN-6-ONE HETNAM EPH L-ALPHA-PHOSPHATIDYL-BETA-OLEOYL-GAMMA-PALMITOYL- HETNAM 2 EPH PHOSPHATIDYLETHANOLAMINE HETSYN P1A PONASTERONE A; 25-DEOXYECDYSTERONE; 25-DEOXY-20- HETSYN 2 P1A HYDROXYECDYSONE, FORMUL 3 P1A C27 H44 O6 FORMUL 4 EPH C39 H68 N O8 P FORMUL 5 HOH *8(H2 O) HELIX 1 1 THR D 291 GLU D 309 1 19 HELIX 2 2 SER D 312 THR D 320 1 9 HELIX 3 3 ASP D 333 GLY D 356 1 24 HELIX 4 4 GLY D 359 ILE D 363 5 5 HELIX 5 5 SER D 364 ARG D 387 1 24 HELIX 6 6 THR D 404 ALA D 411 1 8 HELIX 7 7 MET D 413 SER D 429 1 17 HELIX 8 8 ASP D 433 PHE D 446 1 14 HELIX 9 9 GLN D 454 ASN D 477 1 24 HELIX 10 10 PRO D 481 LEU D 513 1 33 HELIX 11 11 PRO D 519 TRP D 526 1 8 HELIX 12 12 SER A 209 SER A 218 1 10 HELIX 13 13 PRO A 239 LYS A 241 5 3 HELIX 14 14 PHE A 242 ARG A 265 1 24 HELIX 15 15 HIS A 269 LEU A 273 5 5 HELIX 16 16 GLU A 274 GLY A 284 1 11 HELIX 17 17 SER A 285 MET A 299 1 15 HELIX 18 18 ARG A 333 ALA A 339 1 7 HELIX 19 19 VAL A 341 LEU A 352 1 12 HELIX 20 20 LEU A 352 ARG A 360 1 9 HELIX 21 21 ASP A 362 LEU A 375 1 14 HELIX 22 22 ASN A 384 SER A 408 1 25 HELIX 23 23 GLY A 412 LEU A 419 1 8 HELIX 24 24 LEU A 419 PHE A 438 1 20 HELIX 25 25 ALA A 442 THR A 444 5 3 HELIX 26 26 SER A 445 LEU A 454 1 10 SHEET 1 A 3 TYR D 388 ASP D 389 0 SHEET 2 A 3 SER D 394 PHE D 397 -1 O SER D 394 N ASP D 389 SHEET 3 A 3 GLN D 401 TYR D 403 -1 O TYR D 403 N VAL D 395 SHEET 1 B 2 LEU A 322 CYS A 324 0 SHEET 2 B 2 THR A 330 HIS A 332 -1 O LEU A 331 N MET A 323 SITE 1 AC1 17 GLU D 309 GLN D 310 ILE D 339 MET D 342 SITE 2 AC1 17 THR D 343 THR D 346 ARG D 383 VAL D 384 SITE 3 AC1 17 ARG D 387 LEU D 396 PHE D 397 ALA D 398 SITE 4 AC1 17 TYR D 408 MET D 413 VAL D 416 LEU D 420 SITE 5 AC1 17 ASN D 504 SITE 1 AC2 15 LEU A 230 VAL A 238 PRO A 239 PHE A 242 SITE 2 AC2 15 LEU A 249 ASN A 287 LEU A 290 MET A 323 SITE 3 AC2 15 LEU A 331 GLN A 338 ALA A 339 SER A 431 SITE 4 AC2 15 HIS A 434 PHE A 438 LEU A 440 CRYST1 57.401 57.401 302.696 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017421 0.010058 0.000000 0.00000 SCALE2 0.000000 0.020116 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003304 0.00000